|
DCAF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.235200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.436180E-03 |
| Normal-vs-Stage2 |
9.524000E-03 |
| Normal-vs-Stage3 |
2.021800E-01 |
| Normal-vs-Stage4 |
5.264200E-02 |
| Stage1-vs-Stage2 |
2.513600E-01 |
| Stage1-vs-Stage3 |
3.887200E-01 |
| Stage1-vs-Stage4 |
8.931200E-01 |
| Stage2-vs-Stage3 |
1.187050E-01 |
| Stage2-vs-Stage4 |
2.620800E-01 |
| Stage3-vs-Stage4 |
5.777600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.587900E-04 |
| Normal-vs-AfricanAmerican |
2.856000E-01 |
| Normal-vs-Asian |
2.548600E-01 |
| Caucasian-vs-AfricanAmerican |
1.150020E-01 |
| Caucasian-vs-Asian |
7.186600E-01 |
| AfricanAmerican-vs-Asian |
2.524200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.002500E-02 |
| Normal-vs-Female |
1.66379999999577E-06 |
| Male-vs-Female |
1.959000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.209800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.375700E-04 |
| Normal-vs-Age(61-80Yrs) |
9.838100E-03 |
| Normal-vs-Age(81-100Yrs) |
3.112800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.681200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.390200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.300200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.116400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.256800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.070600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.656800E-03 |
| Normal-vs-Grade 2 |
6.186900E-04 |
| Normal-vs-Grade 3 |
1.167540E-02 |
| Normal-vs-Grade 4 |
7.195800E-01 |
| Grade 1-vs-Grade 2 |
6.638800E-01 |
| Grade 1-vs-Grade 3 |
4.987000E-01 |
| Grade 1-vs-Grade 4 |
1.936190E-01 |
| Grade 2-vs-Grade 3 |
4.614600E-01 |
| Grade 2-vs-Grade 4 |
5.121700E-02 |
| Grade 3-vs-Grade 4 |
1.724420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.04470000007151E-07 |
| Normal-vs-ccB subtype |
6.080100E-02 |
| ccA subtype-vs-ccB subtype |
3.794000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.424200E-04 |
| Normal-vs-N1 |
3.815500E-02 |
| N0-vs-N1 |
8.420000E-02 |
|
|
